Merck KGaA's EMD Serono wants to reinforce the importance of starting and staying on a disease-modifying treatment for multiple sclerosis patients. To...

Federal prosecutors have hounded opioid maker Indivior for years over its marketing of Suboxone Film as a safe painkiller despite addiction risks. After snaring more...

When Novartis shelled out $3.9 billion for France-based Advanced Accelerator Applications in 2017, it had blockbuster hopes for AAA’s Lutathera, a radiotherapy to tr...

The vast majority of drugs that make it to American shelves are produced abroad, sometimes in countries that lawmakers worry don't have the nation's best interests a...

In reviewing potential COVID-19 vaccines, FDA Commissioner Stephen Hahn, M.D., has pledged to "not cut corners" or allow politics to affect decision-making. But whil...

MSD's Keytruda (pembrolizumab) has failed to hit key goals in a trial assessing its potential as a first-line treatment for bladder cancer. The Phase III KEYNOTE-3...

Evox Therapeutics has signed a collaboration deal with Eli Lilly centred on brain/CNS disorders, which could net the latter around $1.2 billion in development, regul...